Market Cap 1.78B
Revenue (ttm) 0.00
Net Income (ttm) -422.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,515,000
Avg Vol 1,200,984
Day's Range N/A - N/A
Shares Out 145.22M
Stochastic %K 59%
Beta 1.58
Analysts Strong Sell
Price Target $37.69

Latest News on DNLI

Denali Therapeutics: Vast Pipeline, First Approval Up Ahead

Mar 20, 2025, 2:16 PM EDT - 14 days ago

Denali Therapeutics: Vast Pipeline, First Approval Up Ahead


Why Is Denali Therapeutics Stock Trading Higher On Wednesday?

Jan 15, 2025, 2:26 PM EST - 2 months ago

Why Is Denali Therapeutics Stock Trading Higher On Wednesday?


Denali Therapeutics ALS drug fails in mid-stage trial

Jan 6, 2025, 4:43 PM EST - 3 months ago

Denali Therapeutics ALS drug fails in mid-stage trial


Denali Has A Neurodegenerative Edge Despite Market Skepticism

Nov 16, 2024, 8:56 AM EST - 4 months ago

Denali Has A Neurodegenerative Edge Despite Market Skepticism


Denali's New Summit: Changing Hunter Syndrome Landscape

Oct 2, 2023, 5:26 AM EDT - 1 year ago

Denali's New Summit: Changing Hunter Syndrome Landscape


MPS II And Beyond: Implications Of Denali's Promising Pipeline

Jul 23, 2023, 12:51 AM EDT - 1 year ago

MPS II And Beyond: Implications Of Denali's Promising Pipeline


Denali: Need Patient Data To Justify That High Valuation

Jan 16, 2023, 12:15 PM EST - 2 years ago

Denali: Need Patient Data To Justify That High Valuation


7 Best Small-Cap Stocks to Buy for 2022 and Beyond

Dec 21, 2022, 10:55 AM EST - 2 years ago

7 Best Small-Cap Stocks to Buy for 2022 and Beyond

ARVN AXSM FATE GTLS RCKT